-
Contact Us
Contact Us
Corporate Headquarters
(908)541-8600
Email Inquiries
Investors: investor@enzon.com
Employment Candidates: careers@enzon.com
Partnership Opportunities: partnering@enzon.com
Investigator Initiated Trial Concept Submission
If you are interested in conducting an Investigator Initiated Trial on one of Enzon Pharmaceuticals marketed products, please click here.
For general inquiries, contact us below
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.30 | ||
| Change(%) |  | +0.02 | |
| Volume | 253897 | ||
| 11:22 AM - Feb 23, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
01-21-2009
Enzon Concludes Tender Offer f...
Enzon Concludes Tender Offer for a Portion of Its Debt
-
05-22-2008
Enzon Stockholders Approve Com...
Enzon Stockholders Approve Company Proposals at 2008 Annual Meeting
-
05-20-2008
Enzon Announces Clinical Data...
Enzon Announces Clinical Data From PEG-SN38 and rhMBL Studies at ASCO -- Company will host reception --
-
02-10-2009
Enzon Discontinues Further Dev...
Enzon Discontinues Further Development of rhMBL
-
07-29-2008
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2008 Earnings on Wednesday, August 6, 2008; Conference Call and Webcast to Follow
-
12-08-2008
Enzon Pharmaceuticals Commence...
Enzon Pharmaceuticals Commences Tender Offer For a Portion of its Debt
-
02-12-2008
Enzon Pharmaceuticals to Add N...
Enzon Pharmaceuticals to Add New Independent Director to Board